Back to Results
First PageMeta Content



Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev
Add to Reading List

Document Date: 2015-06-03 16:42:55


Open Document

File Size: 959,07 KB

Share Result on Facebook
UPDATE